These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 323422)

  • 21. [Antihypertensive action of K in rats with DOCA-salt-induced hypertension].
    Sato Y; Fujita T; Yamashita K
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):117-30. PubMed ID: 6662415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of norepinephrine release by presynaptic alpha 2-adrenoceptors in mesenteric vasculature preparations from chronic DOCA-salt hypertensive rats.
    Tsuda K; Tsuda S; Nishio I; Masuyama Y
    Jpn Heart J; 1989 Mar; 30(2):231-9. PubMed ID: 2542635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain catecholamines in spontaneously hypertensive and DOCA-salt hypertensive rats.
    Fujino K
    Acta Med Okayama; 1984 Aug; 38(4):325-40. PubMed ID: 6149670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats.
    Klarr SA; Keep RF; Betz AL
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H646-52. PubMed ID: 7864190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamine synapses and contents in the paraventricular hypothalamic nucleus and nucleus tractus solitarius of DOCA-salt hypertensive rats.
    Hwang BH; Chiueh CC; Severs WB
    Anat Rec; 1984 Aug; 209(4):553-63. PubMed ID: 6476421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation of the nucleus locus coeruleus in DOCA-salt hypertensive rats.
    Chida K; Kawamura H; Hatano M
    Brain Res; 1983 Aug; 273(1):53-8. PubMed ID: 6616232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of saline consumption in the prevention of deoxycorticosterone hypertension in rats by central 6-hydroxydopamine.
    Lewis PJ; Dargie HJ; Dollery CT
    Clin Sci Mol Med; 1975 Apr; 48(4):327-30. PubMed ID: 1126124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central attenuation of aortic baroreceptor reflex in prehypertensive DOCA-salt-loaded rats.
    Nakamura Y; Takeda K; Nakata T; Hayashi J; Kawasaki S; Lee LC; Sasaki S; Nakagawa M; Ijichi H
    Hypertension; 1988 Sep; 12(3):259-66. PubMed ID: 3169941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1995 Mar; 8(3):287-93. PubMed ID: 7794579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered disposition of vascular catecholamines in hypertensive (DOCA-salt) rats.
    Crabb GA; Head RJ; Hempstead J; Berkowitz BA
    Clin Exp Hypertens (1978); 1980; 2(1):129-38. PubMed ID: 7418539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of sodium, sympathetic innervation, and central adrenergic structures on renal vascular responsiveness in DOCA-treated rats.
    Berecek KH; Murray RD; Gross F
    Circ Res; 1980 Nov; 47(5):675-83. PubMed ID: 7418127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension.
    Longhurst PA; Rice PJ; Taylor DA; Fleming WW
    Hypertension; 1988 Aug; 12(2):133-42. PubMed ID: 3410523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat.
    Hoeldtke R; Rogawski M; Wurtman RJ
    Br J Pharmacol; 1974 Feb; 50(2):265-70. PubMed ID: 4425765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat.
    Katholi RE; Naftilan AJ; Oparil S
    Hypertension; 1980; 2(3):266-73. PubMed ID: 6993358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats.
    Rascher W; Schömig A; Dietz R; Weber J; Gross F
    Eur J Pharmacol; 1981 Nov; 75(4):255-63. PubMed ID: 7318911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmented vasodepressor and sympathetic responses to intracerebroventricular injections of diltiazem, a calcium channel blocker, in DOCA-salt hypertensive rats.
    Takahashi H; Okabayashi H; Suga K; Iyoda I; Matsuzawa M; Ikegaki I; Yoshimura M; Ijichi H
    J Hypertens Suppl; 1986 Dec; 4(6):S156-9. PubMed ID: 3475411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.